Atomera Q2 Loss Widens to $6.3M; Cash at $38.4M, GaN Breakthrough Announced
ATOM has more than doubled off its 52-week low of $1.892.
Summary
Atomera reported a Q2 net loss of $6.3 million on $158K revenue, with $38.4 million in cash. The company also announced a GaN-on-Silicon RF breakthrough, showing 1000X lower harmonic distortion, potentially enabling new RF device classes.
Key Events · Earnings and Guidance · ATOM
-
Q2 Net Loss Widens
Net loss of $6.3 million, or $0.17 per share, compared to a $5.0 million loss a year ago. Revenue was $158,000.
-
Cash Position at $38.4M
Cash, equivalents, and short-term investments totaled $38.4 million as of June 30, 2026, up from $19.2 million at year-end 2025, extending runway to approximately 24 months.
-
GaN-on-Silicon RF Breakthrough
MST GaN on Silicon demonstrated over 1000X lower harmonic distortion than control devices and 15X better than the best published external result, potentially enabling high-volume RF applications on low-cost silicon substrates.
-
Customer Engagement Progress
Cleared a key milestone with one of two active GAA customers; re-established value proposition for DRAM 4F2; and a major NAND supplier validated MST's planar periphery boost for AI NAND performance.
Analysis · ATOM · Manufacturing
Atomera's Q2 results show a widening net loss to $6.3 million, or $0.17 per share, on minimal revenue of $158,000. The company's cash position remains strong at $38.4 million, providing a runway of about 24 months based on the prior quarter's guidance. The real story is the technology update: Atomera announced a breakthrough in GaN-on-Silicon for RF applications, claiming 1000X lower harmonic distortion than control devices, which could open a new market. With 39 million shares outstanding and a history of insider selling, the earnings themselves are not a positive surprise, but the technology progress may shift sentiment.
At the time of this filing, ATOM was trading at $5.04 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $218.7M. The 52-week trading range was $1.89 to $12.37. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.